Want to see GB:CNSL full AI Analyst Report?
Total Valuation
Omega Diagnostics has a market cap or net worth of £4.16M. The enterprise value is 3.91 p.
Market Cap£4.16M
Enterprise Value3.91 p
Share Statistics
Omega Diagnostics has 237,950,650 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding237,950,650
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Omega Diagnostics’s return on equity (ROE) is 0.14 and return on invested capital (ROIC) is -5.27%.
Return on Equity (ROE)0.14
Return on Assets (ROA)0.11
Return on Invested Capital (ROIC)-5.27%
Return on Capital Employed (ROCE)-0.05
Revenue Per Employee99.17K
Profits Per Employee18.64K
Employee Count84
Asset Turnover0.60
Inventory Turnover4.01
Valuation Ratios
The current PE Ratio of Omega Diagnostics is 3.1. Omega Diagnostics’s PEG ratio is -0.00809.
PE Ratio3.1
PS Ratio0.87
PB Ratio0.64
Price to Fair Value0.64
Price to FCF-51.18
Price to Operating Cash Flow-25.12
PEG Ratio-0.00809
Income Statement
In the last 12 months, Omega Diagnostics had revenue of 8.33M and earned 1.57M in profits. Earnings per share was <0.01.
Revenue8.33M
Gross Profit5.00M
Operating Income-640.00K
Pretax Income1.57M
Net Income1.57M
EBITDA2.20M
Earnings Per Share (EPS)<0.01
Cash Flow
In the last 12 months, operating cash flow was -166.00K and capital expenditures -271.00K, giving a free cash flow of -437.00K billion.
Operating Cash Flow-166.00K
Free Cash Flow-437.00K
Free Cash Flow per Share>-0.01
Dividends & Yields
Omega Diagnostics pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.80
52-Week Price Change-50.00%
50-Day Moving Average1.78
200-Day Moving Average2.01
Relative Strength Index (RSI)40.86
Average Volume (3m)353.57K
Important Dates
Omega Diagnostics upcoming earnings date is Aug 18, 2026, TBA (Confirmed).
Last Earnings DateNov 10, 2025
Next Earnings DateAug 18, 2026
Ex-Dividend Date―
Financial Position
Omega Diagnostics as a current ratio of 3.62, with Debt / Equity ratio of 2.14%
Current Ratio3.62
Quick Ratio3.23
Debt to Market Cap0.03
Net Debt to EBITDA-2.06
Interest Coverage Ratio-37.65
Taxes
In the past 12 months, Omega Diagnostics has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Omega Diagnostics EV to EBITDA ratio is 1.25, with an EV/FCF ratio of -19.35.
EV to Sales0.33
EV to EBITDA1.25
EV to Free Cash Flow-19.35
EV to Operating Cash Flow33.11
Balance Sheet
Omega Diagnostics has £3.59M in cash and marketable securities with £237.00K in debt, giving a net cash position of £3.36M billion.
Cash & Marketable Securities£3.59M
Total Debt£237.00K
Net Cash£3.36M
Net Cash Per Share£0.01
Tangible Book Value Per Share£0.03
Margins
Gross margin is 60.93%, with operating margin of -7.68%, and net profit margin of 18.80%.
Gross Margin60.93%
Operating Margin-7.68%
Pretax Margin18.80%
Net Profit Margin18.80%
EBITDA Margin26.39%
EBIT Margin19.00%
Analyst Forecast
The average price target for Omega Diagnostics is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-10.20%
EPS Growth Forecast714.29%